对癌症的经济评估来评价生活质量:导航多种方法
Carrie-Anne Ng1, Richard De Abreu Lourenco1, Rosalie Viney1
1Centre for Health Economics Research and Evaluation, Faculty of Health, University of Technology Sydney, Sydney, New South Wales, Australia.
Expert review of pharmacoeconomics & outcomes research
|August 19, 2024
概括
本综述指导癌症研究人员选择生活质量 (QoL) 评估方法进行经济评估. 它涵盖基于偏好的措施 (PBM) 和直接诱导,为最佳癌症研究应用提供建议.
科学领域:
- 卫生经济学 卫生经济学
- 在瘤学瘤学.
- 患者报告的结果
背景情况:
- 实用值量化了癌症治疗对患者生活质量 (QoL) 的影响.
- 不同的QOL估值方法对经济评估中的一致应用提出了挑战.
- 标准化QOL评估对于比较新型癌症疗法至关重要.
研究的目的:
- 为癌症经济评估提供QoL估值方法的全面概述.
- 为癌症临床医生和研究人员在选择适当的QoL评估工具时提供指导.
- 讨论癌症研究的QoL测量的最新进展和考虑.
主要方法:
- 独立和衍生基于优惠的措施 (PBM) 的审查.
- 对直接偏好诱导方法的分析.
- 对癌症特异性与通用PBMs的比较性能的检查.
主要成果:
- 包括PBM和直接诱导技术在内的方法概述.
- 讨论与健康相关的 QoL. QoL. 之外的测量结果.
- 强调越来越多地使用离散选择实验来引起偏好.
结论:
- 预计将继续采用QLU-C10D和FACT-8D等癌症特异性PBM.
- 研究人员在将癌症特异性PBM替换为通用PBM时必须考虑局限性.
- 对于在癌症试验中选择和整合QoL方法的共识是显而易见的.
相关概念视频
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Actuarial Approach
69
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
69
Comparing the Survival Analysis of Two or More Groups
164
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
164
Kaplan-Meier Approach
115
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
115
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


